Related Experiment Video
Updated: Aug 3, 2026

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Diclofenac/N-(2-hydroxyethyl)pyrrolidine: a new salt for an old drug
1Institute of Chemical Sciences, Bologna, Italy.
Abstract:
Twenty-four diclofenac salts were prepared using inorganic and organic, linear and cyclic, hydrophilic and hydrophobic bases and their behaviour in polar and poorly polar solvents was examined. Most salts were found more soluble in 1-octanol than in water, suggesting a fair hydrophobicity of these compounds and their existence as ion pairs in non-polar solvents. The salt diclofenac/N-(2-hydroxyethyl)pyrrolidine (DHEP) is the most soluble of this group in 1-octanol (8.39% w/w) and in water (1.89% w/w), where it displays a surfactant behaviour above 1.44% w/w, which can be considered as a critical micellar concentration. It was possible to study the surface activity of diclofenac only using DHEP, since all other salts of this group are not soluble enough to overcome the critical concentration. The mild detergent properties of DHEP were confirmed by the solubilization of lecithin and the formation of mixed micelles with bile salts: these properties appear very interesting in developing new pharmaceutical forms containing DHEP, as a chemical form for the delivery of the active principle diclofenac.
More Related Videos
08:59A Freeze-Thawing Method to Prepare Chitosan-Poly(vinyl alcohol) Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
Published on: January 14, 2020
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Related Concept Videos
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
FDA Approved Drugs: Changes to Approved Drugs
Drug Dosing: Geriatric Patients
Oral Drug Delivery Systems: Delayed-Release Systems